Abeta aggregation-IN-5 is a brain-penetrant amyloid-beta aggregation inhibitor. Abeta aggregation-IN-5 inhibits Abeta aggregation/oligomerization, rescues cells from AB/ROS toxicity and reduces microglial activation/NO production. Abeta aggregation-IN-5 reduces amyloid burden, neuroinflammation, microglial activation in APP/PSEN1 mice. Abeta aggregation-IN-5 can be used for the research of Alzheimers disease[1].
Molekulargewicht:
563.64
Formel:
C32H37NO8
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
